Should all patients with systemic lupus erythematosus receive cardioprotection with statins?

Nat Clin Pract Rheumatol. 2007 Oct;3(10):536-7. doi: 10.1038/ncprheum0593.

Authors

Sergio Toloza¹, Murray B Urowitz, Dafna D Gladman

Affiliation

¹ Centre for Prognosis Studies in the Rheumatic Diseases at Toronto Western Hospital, in Toronto, ON, Canada.

PMID: 17700557
DOI: 10.1038/ncprheum0593

No abstract available

MeSH terms

Atherosclerosis / drug therapy*
Atherosclerosis / etiology
Cholesterol, LDL / blood
Coronary Disease / etiology
Coronary Disease / prevention & control*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Lupus Erythematosus, Systemic / complications
Lupus Erythematosus, Systemic / drug therapy*
Risk Factors

Substances

Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors